Bioerix Competitors

We are Reckitt, a world-class consumer health and hygiene company. Founded in 1840 in Hull, United Kingdom, we are now home to some of the world's most trusted brands including Dettol, Strepsils, Harpic, Veet, Mucinex, Gaviscon, Durex, Lysol, Finish, and Vanish. We exist to deliver better health in more hands, every day. Our footprint spans more than 80 countries. Every day, millions of people around the world rely on Reckitt brands to care for themselves, the people they love and the homes they live in. Through trusted brands, science-led innovation and deep consumer understanding, we're helping to strengthen communities by making better health and hygiene more accessible, every day. Each of our products is designed to do exactly this. Our well-loved brands have been making a difference to people’s daily lives around the world for more than 200 years. Brands including: Durex, Dettol, Enfamil, Nurofen, Strepsils, Gaviscon, Mucinex, Nutramigen, Lysol, Harpic, Cillit Bang, Finish and Vanish. By 2030, our ambition is to reach half of the world, every year. We’re a growing global community of over 43,000 people on a journey of transformation and sustainable growth. Together, our success will continue to positively impact communities everywhere, for a healthier planet and a fairer society. Want to learn more about us? Visit reckitt.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety. *** 💡 Read our Community Guidelines: https://www.biomerieux.com/corp/en/social-media-community-guidelines.html

Biocodex is a French pharmaceutical company founded in 1953 to develop and market the world’s first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Today, Biocodex focuses its business on three main areas: Microbiota care; Women’s health; Orphan diseases. With more than 1,700 employees, Biocodex generated net revenues of above €500million in 2023, including 1/3 in France and 2/3 internationally. The group is present in more than 100 countries through wholly owned subsidiaries in 16 countries and a network of distributors worldwide. To report quality complaint(s) or adverse event(s) related to Biocodex products please visit https://www.biocoreport.com/en/